pentamethylmelamine has been researched along with Plasma Cell Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldin, A; Green, D; Morimoto, M; Rahman, A; Schein, PS | 1 |
| Abel, G; Goddard, PM; Harrap, KR; Judson, IR; Newell, DR; Rutty, CJ | 1 |
2 other study(ies) available for pentamethylmelamine and Plasma Cell Tumor
| Article | Year |
|---|---|
Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
Topics: Alkylating Agents; Altretamine; Animals; DNA Replication; DNA, Neoplasm; Leukocyte Count; Male; Mice; Microsomes, Liver; Neoplasms, Experimental; Plasmacytoma; RNA, Neoplasm; Triazines | 1980 |
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.
Topics: Altretamine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Kinetics; Male; Mice; Mice, Inbred BALB C; Plasmacytoma; Rats; Rats, Inbred Strains; Solubility; Triazines | 1986 |